- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x HSX: 5-O-phosphono-alpha-D-ribofuranose(Non-covalent)
HSX.2: 13 residues within 4Å:- Chain A: H.130, D.171, D.220, D.221, M.222, A.223, D.224, T.225, C.226, G.227, T.228
- Ligands: ATP.1, MG.5
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:H.130, A:D.221, A:D.224, A:T.225, A:C.226, A:G.227, A:T.228, A:T.228, A:T.228
HSX.12: 12 residues within 4Å:- Chain C: H.130, D.171, D.220, D.221, M.222, D.224, T.225, C.226, G.227, T.228
- Ligands: ATP.11, MG.15
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:H.130, C:D.224, C:D.224, C:D.224, C:T.225, C:C.226, C:G.227, C:T.228, C:T.228, C:T.228
- Salt bridges: C:H.130
HSX.17: 12 residues within 4Å:- Chain D: H.130, D.171, D.220, D.221, M.222, D.224, T.225, C.226, G.227, T.228
- Ligands: ATP.16, MG.20
10 PLIP interactions:10 interactions with chain D- Hydrogen bonds: D:H.130, D:D.224, D:D.224, D:T.225, D:C.226, D:G.227, D:T.228, D:T.228, D:T.228
- Salt bridges: D:H.130
HSX.22: 12 residues within 4Å:- Chain E: H.130, D.171, D.220, D.221, M.222, D.224, T.225, C.226, G.227, T.228
- Ligands: ATP.21, MG.25
11 PLIP interactions:11 interactions with chain E- Hydrogen bonds: E:H.130, E:D.224, E:D.224, E:D.224, E:T.225, E:C.226, E:G.227, E:T.228, E:T.228, E:T.228
- Salt bridges: E:H.130
HSX.27: 12 residues within 4Å:- Chain F: H.130, D.171, D.220, D.221, M.222, D.224, T.225, C.226, G.227, T.228
- Ligands: ATP.26, MG.30
10 PLIP interactions:10 interactions with chain F- Hydrogen bonds: F:H.130, F:D.224, F:D.224, F:T.225, F:C.226, F:G.227, F:T.228, F:T.228, F:T.228
- Salt bridges: F:H.130
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.3: 6 residues within 4Å:- Chain A: S.308, V.309, S.310
- Chain B: R.104
- Chain F: S.47, R.49
5 PLIP interactions:1 interactions with chain F, 3 interactions with chain A, 1 interactions with chain B- Salt bridges: F:R.49, B:R.104
- Hydrogen bonds: A:V.309, A:S.310, A:S.310
PO4.8: 7 residues within 4Å:- Chain A: R.104
- Chain B: E.307, S.308, V.309, S.310
- Chain C: S.47, R.49
5 PLIP interactions:3 interactions with chain B, 1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: B:E.307, B:V.309, B:S.310
- Salt bridges: A:R.104, C:R.49
PO4.13: 6 residues within 4Å:- Chain C: S.308, V.309, S.310
- Chain D: R.104
- Chain E: S.47, R.49
6 PLIP interactions:4 interactions with chain C, 1 interactions with chain E, 1 interactions with chain D- Hydrogen bonds: C:S.308, C:S.308, C:V.309, C:S.310
- Salt bridges: E:R.49, D:R.104
PO4.18: 6 residues within 4Å:- Chain A: S.47, R.49
- Chain C: R.104
- Chain D: S.308, V.309, S.310
5 PLIP interactions:3 interactions with chain D, 1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: D:V.309, D:S.310, D:S.310
- Salt bridges: C:R.104, A:R.49
PO4.23: 6 residues within 4Å:- Chain B: S.47, R.49
- Chain E: S.308, V.309, S.310
- Chain F: R.104
6 PLIP interactions:4 interactions with chain E, 1 interactions with chain B, 1 interactions with chain F- Hydrogen bonds: E:S.308, E:S.308, E:V.309, E:S.310
- Salt bridges: B:R.49, F:R.104
PO4.28: 6 residues within 4Å:- Chain D: S.47, R.49
- Chain E: R.104
- Chain F: S.308, V.309, S.310
5 PLIP interactions:3 interactions with chain F, 1 interactions with chain D, 1 interactions with chain E- Hydrogen bonds: F:V.309, F:S.310, F:S.310
- Salt bridges: D:R.49, E:R.104
- 12 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 2 residues within 4Å:- Chain A: H.130
- Ligands: ATP.1
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:H.130, H2O.1, H2O.1
MG.5: 2 residues within 4Å:- Chain A: D.171
- Ligands: HSX.2
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.171
MG.9: 3 residues within 4Å:- Chain B: H.130
- Ligands: PRP.6, AMP.7
4 PLIP interactions:1 interactions with chain B, 2 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: B:H.130, H2O.1, H2O.1, AMP.7
MG.10: 4 residues within 4Å:- Chain B: D.171, D.220, D.221
- Ligands: PRP.6
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.171, B:D.171
MG.14: 3 residues within 4Å:- Chain C: K.99, H.130
- Ligands: ATP.11
3 PLIP interactions:1 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:H.130, H2O.1, H2O.1
MG.15: 3 residues within 4Å:- Chain C: D.171, D.220
- Ligands: HSX.12
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:D.171
MG.19: 3 residues within 4Å:- Chain D: K.99, H.130
- Ligands: ATP.16
3 PLIP interactions:1 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:H.130, H2O.1, H2O.1
MG.20: 3 residues within 4Å:- Chain D: D.171, D.220
- Ligands: HSX.17
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:D.171
MG.24: 3 residues within 4Å:- Chain E: K.99, H.130
- Ligands: ATP.21
3 PLIP interactions:1 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:H.130, H2O.1, H2O.1
MG.25: 3 residues within 4Å:- Chain E: D.171, D.220
- Ligands: HSX.22
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:D.171
MG.29: 3 residues within 4Å:- Chain F: K.99, H.130
- Ligands: ATP.26
3 PLIP interactions:1 interactions with chain F, 2 Ligand-Water interactions- Metal complexes: F:H.130, H2O.1, H2O.1
MG.30: 3 residues within 4Å:- Chain F: D.171, D.220
- Ligands: HSX.27
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:D.171
- 1 x PRP: 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose(Non-covalent)
PRP.6: 18 residues within 4Å:- Chain B: R.96, H.130, D.171, G.173, K.194, R.196, D.220, D.221, M.222, A.223, D.224, T.225, C.226, G.227, T.228
- Ligands: AMP.7, MG.9, MG.10
23 PLIP interactions:23 interactions with chain B- Hydrogen bonds: B:D.171, B:A.172, B:G.173, B:K.194, B:D.220, B:D.224, B:T.225, B:C.226, B:G.227, B:T.228, B:T.228, B:T.228
- Water bridges: B:D.98, B:H.130
- Salt bridges: B:H.130, B:H.130, B:H.130, B:K.194, B:K.194, B:K.194, B:R.196, B:R.196, B:R.196
- 1 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
AMP.7: 11 residues within 4Å:- Chain A: K.176
- Chain B: R.96, Q.97, K.99, D.101, N.200
- Chain F: F.35, N.37, E.39
- Ligands: PRP.6, MG.9
10 PLIP interactions:4 interactions with chain B, 5 interactions with chain F, 1 interactions with chain A- Hydrogen bonds: B:Q.97, B:D.101, B:D.224, F:N.37, F:N.37, F:E.39
- Salt bridges: B:K.99, A:K.176
- pi-Stacking: F:F.35, F:F.35
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hvorecny, K.L. et al., Human PRPS1 filaments stabilize allosteric sites to regulate activity. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-02-15
- Peptides
- Ribose-phosphate pyrophosphokinase 1: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x HSX: 5-O-phosphono-alpha-D-ribofuranose(Non-covalent)
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
- 12 x MG: MAGNESIUM ION(Non-covalent)
- 1 x PRP: 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose(Non-covalent)
- 1 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hvorecny, K.L. et al., Human PRPS1 filaments stabilize allosteric sites to regulate activity. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-02-15
- Peptides
- Ribose-phosphate pyrophosphokinase 1: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F